Shionogi Says High U.K. Drug Standards Behind Europe HQ Decision
This article was originally published in PharmAsia News
Executive Summary
Shionogi lauds tougher standards imposed on drug approvals and pricing led the Japanese drug maker to locate its European headquarters in the U.K.